and/or
30 Faculty members found
Human Oncology & Pathogenesis Program
Physician-Scientist A. Ari Hakimi, MD studies genetic and metabolic mechanisms of immune response in kidney cancers.
The Adrienne Boire Lab
Human Oncology & Pathogenesis Program
Physician-scientist Adrienne Boire studies metastasis to the central nervous system.
Andrew Intlekofer Lab Group
Human Oncology & Pathogenesis Program
Physician-scientist Andrew Intlekofer investigates why cancer cells depend on specific pathways of nutrient metabolism.
Human Oncology & Pathogenesis Program
The Minn Lab investigates how cancers evolve under chronic inflammation and persistent immune pressure to acquire resistance to immunotherapies, with the goal of developing innovative therapies to restore anti-tumor immunity.
Human Oncology & Pathogenesis Program
The Tulpule lab studies how cells compartmentalize critical cellular processes with a focus on biomolecular condensates in cancer.
The Charles Sawyers Lab
Human Oncology & Pathogenesis Program
Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.
The Christine Iacobuzio-Donahue Lab
Memorial Hospital Research Laboratories
Physician-scientist Christine Iacobuzio-Donahue studies the genomics and cell biology of pancreatic and other solid tumors as it relates to subclonal evolution, tumor progression, and metastasis.
Immuno-Oncology Program
The Brown Lab studies how the tissue environment shapes immune cell fate and function during early life immune development, inflammation, and cancer.
The David Solit Lab
Human Oncology & Pathogenesis Program
Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.
The Cheng Lab
Human Oncology & Pathogenesis Program
Physician-scientist Emily Cheng studies the molecular mechanisms of cell death and their implications in tumorigenesis, tumor-microenvironment interactions, targeted therapy, and immunotherapy.